Global Osteoporosis Drugs Market exhibited a CAGR of 2.6%, and is expected to increase 1.3X over the forecast of 2023-2031 | PMR Study

The market for osteoporosis drugs is expected to witness considerable growth in the coming years, driven by increasing prevalence of the condition and rising awareness about preventive as well as curative treatments.

Osteoporosis is a bone-weakening disease caused due to low bone mass and deterioration of bone tissue. It can lead to fractures and other debilitating conditions such as spinal deformities and increased risk of mortality. Various types of drugs are available for treating this condition including bisphosphonates, hormones, selective estrogen receptor modulators (SERMs) and calcitonin among others.

Furthermore, several new treatments are under development that could prove to be more effective than existing options in the near future. For instance, denosumab - a monoclonal antibody drug - has been approved by the US FDA for treatment of postmenopausal women with osteoporosis.

Request For Free Sample Report of "Osteoporosis Drugs Market"@ https://www.persistencemarketresearch.com/samples/2983

The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market.

However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.

In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region.

According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.

Companies

Eli Lilly and Company
Hoffmann-La Roche Ltd.
Merck & Co, Inc.
Novartis AG
Amgen, Inc.
Novo Nordisk A/S
Actavis plc
Pfizer, Inc.
GlaxoSmithKline plc
Teva Pharmaceutical Industries Ltd
Other

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/2983

Market Segmentation:

By Drug Type

Bisphosphonates

Parathyroid Hormone Therapy Drugs

Calcitonin

Selective Estrogen Receptors Modulators (SERMs)

RANK Ligand Inhibitors

 By Geography

North America

The U.S.

Europe

Germany

France

The U.K.

Asia

China

Japan

India

Rest of the World (RoW)

Request Customization @ https://www.persistencemarketresearch.com/request-customization/2983

Key Questions Answered in This Report.

What are the Roadblocks for Osteoporosis Drugs Market Suppliers?
What are the Key Opportunities for Osteoporosis Drugs Market Manufacturers?
How is Focus on Safety Influencing Osteoporosis Drugs Market Demand?
What is the Regulatory Impact on Global Sales of Osteoporosis Drugs Market?
Which Region Offers the Largest Opportunity for Sales of Osteoporosis Drugs Market?
Where Does the U.S. Stand in the Market for Osteoporosis Drugs Market?
What Is the Outlook for Osteoporosis Drugs Market Manufacturers in China?
Why is Germany a Lucrative Market for Osteoporosis Drugs Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Osteoporosis Drugs Market?
Why is There High Demand for Tires in Osteoporosis Drugs Market?
Why are Sales of Osteoporosis Drugs Market Surging?

For More Premium Insights, Check out the Link:

Infectious Disease In Vitro Diagnostics Market - https://www.medgadget.com/2023/01/infectious-disease-in-vitro-diagnostics-market-develop-at-a-cagr-of-4-1-in-the-united-states-and-expected-to-reach-us-93-9-bn-by-2032.html

Macular Degeneration Treatment Market - https://www.medgadget.com/2023/01/macular-degeneration-treatment-market-is-estimated-to-surge-ahead-at-a-cagr-of-7-4-to-reach-us-18-8-bn-by-the-end-of-2032-pmr.html

Medical Beds Market- https://www.medgadget.com/2023/01/medical-beds-market-is-estimated-to-move-ahead-at-a-cagr-of-5-8-to-reach-us-22-6-bn-by-the-end-of-2032-hill-rom-holdings-inc-invacare-corporation-drive-medical-stryker-corporation.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.